SEC Form 4 · accession 0000899243-17-023693
Global Blood Therapeutics, Inc. · GBT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles J Homcy
Director
Period of report
Oct 3, 2017
Accepted (ET)
Oct 5, 2017 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001629137
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Oct 3, 2017 | S$0 | 0 | $0.00 | D | 0 | I | See Footnote |
| Common StockF4,F5,F6 | Oct 3, 2017 | S$0 | 0 | $0.00 | D | 0 | I | See Footnote |
| Common StockF7,F8,F3 | Oct 4, 2017 | S$0 | 0 | $0.00 | D | 0 | I | See Footnote |
| Common StockF9,F10,F6 | Oct 4, 2017 | S$0 | 0 | $0.00 | D | 0 | I | See Footnote |
| Common StockF11,F12,F3 | Oct 4, 2017 | S$0 | 0 | $0.00 | D | 0 | I | See Footnote |
| Common StockF13,F14,F6 | Oct 4, 2017 | S$0 | 0 | $0.00 | D | 0 | I | See Footnote |
| Common Stock | holding | — | — | — | 137,728 | D | ||
| Common Stock | holding | — | — | — | 1,600 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On October 3, 2017, Third Rock Ventures II, L.P. ("TRV II") sold 62,373 shares of Common Stock of the Issuer. The shares were sold at a weighted average price of $30.171. These shares were sold in multiple transactions at prices ranging from $29.75 to $30.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (4), (7), (9), (11) and (13) to this Form 4.
- F10After the transaction referenced in footnote (9), TRV III owned 150,918 shares.
- F11On October 4, 2017, TRV II sold 129,902 shares of Common Stock of the Issuer. The shares were sold at a weighted average price of $30.86. These shares were sold in multiple transactions at prices ranging from $30.65 to $31.15, inclusive.
- F12After the transaction referenced in footnote (11), TRV II owned 1,089,478 shares.
- F13On October 4, 2017, TRV III sold 150,918 shares of Common Stock of the Issuer. The shares were sold at a weighted average price of $30.86. These shares were sold in multiple transactions at prices ranging from $30.65 to $31.15, inclusive.
- F14After the transaction referenced in footnote (13), TRV III owned no shares.
- F2After the transaction referenced in footnote (1), TRV II owned 1,273,032 shares.
- F3The reporting person is a partner of Third Rock Ventures GP II, L.P., which is the general partner of TRV II. The reporting person disclaims beneficial ownership over the shares held by TRV II, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such shares.
- F4On October 3, 2017, Third Rock Ventures III, L.P. ("TRV III") sold 72,463 shares of Common Stock of the Issuer. The shares were sold at a weighted average price of $30.171. These shares were sold in multiple transactions at prices ranging from $29.75 to $30.55, inclusive.
- F5After the transaction referenced in footnote (4), TRV III owned 213,250 shares.
- F6The reporting person is a partner of Third Rock Ventures GP III, L.P., which is the general partner of TRV III. The reporting person disclaims beneficial ownership over the shares held by TRV III, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such shares.
- F7On October 4, 2017, TRV II sold 53,652 shares of Common Stock of the Issuer. The shares were sold at a weighted average price of $30.38. These shares were sold in multiple transactions at prices ranging from $29.60 to $30.60, inclusive.
- F8After the transaction referenced in footnote (7), TRV II owned 1,219,380 shares.
- F9On October 4, 2017, TRV III sold 62,332 shares of Common Stock of the Issuer. The shares were sold at a weighted average price of $30.38. These shares were sold in multiple transactions at prices ranging from $29.60 to $30.60, inclusive.